A new federal rule is ending Medicaid coverage for gender-affirming hormone therapies and procedures for young people. (Photo by Dana DiFilippo/New Jersey Monitor)
Nada Hassanein is a Health Care Inequities Reporter at Stateline. She specializes in health and wellness issues, focusing on health inequities, public health, and the healthcare system, while also addressing topics such as mental health and environmental impacts on health. Nada's work has been featured in prominent publications including the Detroit Free Press, USA TODAY, and The Washington Post.














